323 related articles for article (PubMed ID: 26292662)
1. Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.
Borin TF; Arbab AS; Gelaleti GB; Ferreira LC; Moschetta MG; Jardim-Perassi BV; Iskander AS; Varma NR; Shankar A; Coimbra VB; Fabri VA; de Oliveira JG; Zuccari DA
J Pineal Res; 2016 Jan; 60(1):3-15. PubMed ID: 26292662
[TBL] [Abstract][Full Text] [Related]
2. ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration.
Ortíz-López L; Morales-Mulia S; Ramírez-Rodríguez G; Benítez-King G
J Pineal Res; 2009 Jan; 46(1):15-21. PubMed ID: 18482340
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines.
Leonel C; Ferreira LC; Borin TF; Moschetta MG; Freitas GS; Haddad MR; de Camargos Pinto Robles JA; Aparecida Pires de Campos Zuccari D
Anticancer Agents Med Chem; 2017; 17(8):1113-1125. PubMed ID: 28042775
[TBL] [Abstract][Full Text] [Related]
5. ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells.
Bhandary L; Whipple RA; Vitolo MI; Charpentier MS; Boggs AE; Chakrabarti KR; Thompson KN; Martin SS
Oncotarget; 2015 Mar; 6(8):6251-66. PubMed ID: 25749040
[TBL] [Abstract][Full Text] [Related]
6. Rho‑associated kinase inhibitor, Y‑27632, inhibits the invasion and proliferation of T24 and 5367 bladder cancer cells.
Jiang L; Wen J; Luo W
Mol Med Rep; 2015 Nov; 12(5):7526-30. PubMed ID: 26459851
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy.
Opyrchal M; Allen C; Msaouel P; Iankov I; Galanis E
Cancer Gene Ther; 2013 Nov; 20(11):630-7. PubMed ID: 24157925
[TBL] [Abstract][Full Text] [Related]
8. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo.
Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Wang WJ; Li QQ; Chen Q; Xu ZD; Liu XP
Breast Cancer Res Treat; 2010 Sep; 123(2):375-86. PubMed ID: 19946739
[TBL] [Abstract][Full Text] [Related]
9. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
Voorneveld PW; Kodach LL; Jacobs RJ; Liv N; Zonnevylle AC; Hoogenboom JP; Biemond I; Verspaget HW; Hommes DW; de Rooij K; van Noesel CJ; Morreau H; van Wezel T; Offerhaus GJ; van den Brink GR; Peppelenbosch MP; Ten Dijke P; Hardwick JC
Gastroenterology; 2014 Jul; 147(1):196-208.e13. PubMed ID: 24704720
[TBL] [Abstract][Full Text] [Related]
10. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.
Hakuma N; Kinoshita I; Shimizu Y; Yamazaki K; Yoshida K; Nishimura M; Dosaka-Akita H
Cancer Res; 2005 Dec; 65(23):10776-82. PubMed ID: 16322223
[TBL] [Abstract][Full Text] [Related]
11. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
[TBL] [Abstract][Full Text] [Related]
12. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers of angiogenesis and metastasis in lines of oral carcinoma after treatment with melatonin.
Goncalves Ndo N; Rodrigues RV; Jardim-Perassi BV; Moschetta MG; Lopes JR; Colombo J; Zuccari DA
Anticancer Agents Med Chem; 2014; 14(9):1302-11. PubMed ID: 25323035
[TBL] [Abstract][Full Text] [Related]
14. Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer.
Jardim-Perassi BV; Arbab AS; Ferreira LC; Borin TF; Varma NR; Iskander AS; Shankar A; Ali MM; de Campos Zuccari DA
PLoS One; 2014; 9(1):e85311. PubMed ID: 24416386
[TBL] [Abstract][Full Text] [Related]
15. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
Man K; Ng KT; Xu A; Cheng Q; Lo CM; Xiao JW; Sun BS; Lim ZX; Cheung JS; Wu EX; Sun CK; Poon RT; Fan ST
Clin Cancer Res; 2010 Feb; 16(3):967-77. PubMed ID: 20103676
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells.
Li B; Zhao WD; Tan ZM; Fang WG; Zhu L; Chen YH
FEBS Lett; 2006 Jul; 580(17):4252-60. PubMed ID: 16828752
[TBL] [Abstract][Full Text] [Related]
17. The effect of local rho-kinase inhibition on murine wound healing.
Tholpady SS; DeGeorge BR; Campbell CA
Ann Plast Surg; 2014; 72(6):S213-9. PubMed ID: 24691315
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer.
Lacerda JZ; Ferreira LC; Lopes BC; Aristizábal-Pachón AF; Bajgelman MC; Borin TF; Zuccari DAPC
Microrna; 2019; 8(3):237-247. PubMed ID: 30806335
[TBL] [Abstract][Full Text] [Related]
19. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.
Gonçalves Ndo N; Colombo J; Lopes JR; Gelaleti GB; Moschetta MG; Sonehara NM; Hellmén E; Zanon Cde F; Oliani SM; Zuccari DA
PLoS One; 2016; 11(3):e0150407. PubMed ID: 26934679
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth.
Routhier A; Astuccio M; Lahey D; Monfredo N; Johnson A; Callahan W; Partington A; Fellows K; Ouellette L; Zhidro S; Goodrow C; Smith A; Sullivan K; Simone P; Le L; Vezuli B; Zohni M; West E; Gleason D; Bryan B
Oncol Rep; 2010 Mar; 23(3):861-7. PubMed ID: 20127030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]